The Horse

MAR 2019

The Horse:Your Guide To Equine Health Care provides monthly equine health care information to horse owners, breeders, veterinarians, barn/farm managers, trainer/riding instructors, and others involved in the hands-on care of the horse.

Issue link: https://thehorse.epubxp.com/i/1080930

Contents of this Issue

Navigation

Page 9 of 75

AAEP FORUM TheHorse.com/AAEP-Forum SALLYANNE L. DENOTTA, DVM, PHD, DIPL. ACVIM 10 March 2019 The Horse | TheHorse.com W hen it comes to horse health, there are rarely any guarantees. Even horses with impeccable manage- ment can fall victim to illness or injury at any time. Thankfully, we can prevent some serious diseases, such as West Nile virus (WNV), easily and effectively through proper vaccination. The American Association of Equine Practitioners has included WNV on its list of core vaccines, meaning it's recom- mended for all horses regardless of where they live or whether they travel. Yet in 2018 there were 363 equine cases of WNV across 41 states. Most, if not all, of these cases could have been prevented with proper vaccination. Measures you can take to help protect your horse against WNV include adopting management strategies to reduce mosquito exposure and immunizing against the disease. With mosquito season approaching, now is the time to make a plan for WNV prevention. West Nile virus is a member of the Fla- viviridae family in the genus Flavivirus. It was first introduced into the U.S. in 1999 and spread rapidly across all 48 contigu- ous states in the years following, resulting in thousands of equine infections. Various wild bird species, particularly passerines, can carry high levels of virus and serve as reservoirs for it. Mosquitoes transmit the virus by feeding on the blood of infected birds and then on susceptible species such as horses and humans. Upon transmission to a susceptible host, the virus crosses the blood-brain barrier and damages the brain and spinal cord. Infected horses that develop illness show neurologic signs, such as ataxia (limb incoordination, especially of the hind limbs) and stumbling; face, neck, or trunk muscle twitching; and fever. Many horses also exhibit behavioral changes, such as hyperreactivity or depression. In severe cases horses might progress to recumbency (unable to rise), paralysis, coma, and death. Other infected horses might never show clinical signs. Veterinarians diagnose WNV in horses based on clinical signs and the detection of specific types of antibodies to WNV in the blood. Measuring IgG antibody levels, called IgG titers, can give veterinarians information regarding the horse's vacci- nation, while elevated IgM titers indicate acute WNV infection. The virus itself can also occasionally be found in blood, serum, and cerebrospinal fluid using a PCR test. There is no specific treatment for WNV. Infected horses with clinical signs often benefit from supportive care, including anti- inflammatories, analge- sics, and intravenous fluids. Many horses recover partially or fully. Horses that become recumbent carry a poor progno- sis and are often euthanized. Vaccination Is Key An equine vaccine for WNV became available in 2001 and was fully licensed by the USDA in 2003. Widespread vaccina- tion efforts resulted in a dramatic drop in infection rates across the country. Both the killed and recombinant forms of the WNV vaccine promote excellent im- munity when administered according to recommendations. For both vaccine types veterinarians recommend administering an initial two-dose series, four to six weeks apart. The second booster vaccine is crucial for protective immunization, and horses that only receive the first vac- cine are not considered fully protected. Following this initial vaccine series, your veterinarian should administer regular boosters at least annually. While each of the available WNV vaccines have been shown to provide protection for 12 months, in the southern states where mosquitoes remain active throughout the year, many vets recommend horses re- ceive boosters every six months to ensure strong protective immunity. Foals from vaccinated mares should receive an initial three-vaccine series starting at 4-6 months of age, while foals from unvaccinated mares might need to receive their initial vaccines earlier to be fully protected. It is important to give vaccinations at least a month prior to mosquito season to allow for protective immunity to develop before infection risk. Consult your vet- erinarian for recommended vaccination schedules in your region. Reduce the Source Mosquito control represents another crucial component for reducing WNV risk to your horse and yourself. Eliminating mosquito breeding grounds by remov- ing sources of standing water can reduce populations on farms dramatically. Clean and refill water troughs regularly. Fly sprays containing pyrethrin are effective mosquito repellents and should be applied regularly. Remove birds (including chick- ens) and nests from barns. Also protect yourself from WNV by wearing protective clothing and mosquito repellent. With so many unforeseeable equine health risks, it's crucial that we take ac- tion to prevent the avoidable diseases. Mosquito season will be upon us soon, and now is the time to consult your veter- inarian and make a plan to prevent WNV from affecting you and your horses. h West Nile Virus: Prevent the Preventable Protect your horse against WNV by vaccinating him and reducing mosquito exposure. ISTOCK.COM American Association of Equine Practitioners, 4033 Iron Works Parkway, Lexington, KY 40511 • 859/233-0147 • www.aaep.org

Articles in this issue

Links on this page

Archives of this issue

view archives of The Horse - MAR 2019